Clinical trials: ATRIAL FLUTTER
Emergencies, Heart Failure
The Use of a Monitoring Device by General Practitioners During Out-of-hours Care
All calls that end up on the out-of-hours general practitioners' service (OHGPS), which contain a demand for an urgent home visit, are passed on to the on-call general practitioner (GP).
- Conditions
- Emergencies, Heart Failure, Pulmonary Embolism, Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- Trial name
- NCT05222711
- Testing
- Use of the PICO(TM) monitoring device
- Where
- Belgium
- Volunteers
- 866 people
- Sponsor
- KU Leuven
Atrial Fibrillation or Atrial Flutter, Thrombosis of Left Atrial Appendage
Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
The primary objective of this study is to assess whether Dabigatran leads to a faster complete left atrial appendage (LAA) thrombus resolution as compared to Phenprocoumon.
- Trial name
- RE-LATED_AF (NCT02256683)
- Testing
- Dabigatran etexilate, Phenprocoumon
- Where
- 14 sites in Germany
- Volunteers
- 64 people
- Sponsor
- Johannes Gutenberg University Mainz
Atrial Fibrillation, Atrial Flutter
Anteroposterior Versus Anterolateral Electrode Position for Electrical Cardioversion of Atrial Fibrillation
Atrial fibrillation is the most common heart rhythm disorder (arrhythmia) worldwide. Nearly 40 million people are affected by atrial fibrillation worldwide, and this number is expected to increase by over 50% by 2050.
- Trial name
- SHOCK-VECTOR (NCT05511389)
- Testing
- Anterolateral electrode position, Anteroposterior electrode position, Manual pressure
- Where
- 4 sites in Canada
- Volunteers
- 1,750 people
- Sponsor
- McMaster University
Arrhythmias, Cardiac, Atrial Fibrillation
Physician Acceptance of the NeuTrace System for Cardiac Electroanatomic Mapping
The trial is a prospective, non-randomized, single-arm feasibility trial to evaluate physician acceptance of the NeuTrace System v1.0 for cardiac electroanatomic mapping.
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter
- Trial name
- NCT05214170
- Testing
- Electroanatomic mapping with the NeuTrace System
- Where
- Lithuania
- Volunteers
- 20 people
- Sponsor
- NeuTrace, Inc.
Atrial Fibrillation and Flutter, Atrial Fibrillation
HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
Pulmonary vein isolation (PVI) using the cryoballoon has been proven equal to RF-PVI and is widely used. High Power Short Duration Ablation in RF-PVI has been successfully tested in several trials.
- Conditions
- Atrial Fibrillation and Flutter, Atrial Fibrillation, Paroxysmal Atrial Fibrillation
- Trial name
- HIPAF (NCT04855890)
- Testing
- Ablation
- Where
- Germany
- Volunteers
- 170 people
- Sponsor
- Universitätsklinikum Köln
Atrial Flutter
MIFI Flutter Registry - Ablation of Atrial Flutter With IntellaTip Sensor Technology
Prospective Atrial Flutter Ablation Registry investigating IntellaTip Mifi XP 8 mm technology and MVG isthmus ablation approach Design: National, multi-centre, prospective observational registry documenting right atrial isthmus…
- Trial name
- MIFI (NCT02810938)
- Testing
- Ablation of atrial flutter
- Volunteers
- 121 people
- Sponsor
- Stiftung Institut fuer Herzinfarktforschung
Atrial Fibrillation, Atrial Flutter
Prague Registry of Electric Cardioversion
This single-center observational registry follows contemporary efficacy and short-term complications of elective electric cardioversion.
- Conditions
- Atrial Fibrillation, Atrial Flutter, Atrial Arrhythmia, Atrial Tachycardia
- Trial name
- PRAGUE-ECV (NCT04919902)
- Testing
- Electric cardioversion
- Where
- Czechia
- Volunteers
- 5,000 people
- Sponsor
- Institute for Clinical and Experimental Medicine
Atrium; Fibrillation, Chronic Kidney Diseases
Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
VISIONAIRE (Vitamin K AntagonISt, Factor Xa Inhibitor Or Nothing In Atrial Fibrillation And DIalytic End-stage Renal DiseasE) trial will be a prospective randomized open-label with blinded endpoint adjudication trial including…
- Trial name
- VISIONAIRE (NCT06402851)
- Testing
- Anticoagulant Oral
- Where
- 6 sites in Brazil
- Volunteers
- 1,500 people
- Sponsor
- Hospital Sirio-Libanes
Atrial Fibrillation, Inflammation
Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation
Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated.
- Conditions
- Atrial Fibrillation, Inflammation, Atrial Flutter
- Trial name
- NCT00142194
- Where
- 2 sites in United States
- Volunteers
- 47 people
- Sponsor
- Emory University
Atrial Flutter
Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8)
The purpose of this study is to demonstrate the advantage of using a gold alloy tip electrode over a platinum/iridium alloy tip electrode in ablation of the cavotricuspid isthmus in patients with atrial flutter.
- Trial name
- NCT00326001
- Testing
- Gold tip catheter, Platinum-iridium tip catheter
- Where
- 28 sites in Czechia, Germany and 1 more
- Volunteers
- 463 people
- Sponsor
- Biotronik SE & Co. KG
Symptomatic Atrial Fibrillation, Atrial Flutter
Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm
Evaluate the safety and efficacy of a single oral dose of vanoxerine compared to placebo, in a dose modification manner, on the conversion of symptomatic atrial fibrillation (a-fib) or flutter of recent onset to normal sinus…
- Trial name
- COR-ART (NCT01691313)
- Testing
- Vanoxerine
- Where
- 6 sites in Israel, Russia
- Volunteers
- 104 people
- Sponsor
- Laguna Pharmaceuticals, Inc.
Atrial Fibrillation, Atrial Flutter
Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
Atrial Flutter [AFL] is a relatively frequent arrhythmia, considered as benign, but associated with both invalidating symptoms and thromboembolic risk.
- Trial name
- PREFACE (NCT00736294)
- Testing
- Ramipril
- Where
- 8 sites in France
- Volunteers
- 198 people
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Stroke, Transient Ischemic Attack
30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event
Atrial fibrillation is the most common cardiac cause of ischemic stroke. Detecting atrial fibrillation after a stroke or TIA is critical because highly effective secondary stroke prevention therapy is available for individuals…
- Conditions
- Stroke, Transient Ischemic Attack, Atrial Fibrillation, Atrial Flutter
- Trial name
- EMBRACE (NCT00846924)
- Testing
- a 30-day ambulatory cardiac event monitor, 24-hour Holter
- Where
- 17 sites in Canada
- Volunteers
- 564 people
- Sponsor
- Sunnybrook Health Sciences Centre
Atrial Fibrillation, Atrial Flutter
Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery
The purpose of this study is to demonstrate the safety and efficacy of RSD1235 compared to placebo in the conversion of atrial arrhythmia to sinus rhythm in subjects following valvular and/or coronary artery bypass graft surgery.
- Trial name
- NCT00125320
- Testing
- RSD1235
- Where
- 22 sites in United States, Argentina and 4 more
- Volunteers
- 190 people
- Sponsor
- Astellas Pharma Inc
Atrial Fibrillation and Flutter
Effect of Targeted Education for Atrial Fibrillation Patients
The aim of this study is to evaluate the effect of targeted in-person and online education on cardiovascular outcomes of AF patients (inpatient and outpatient), compared with standard care. Several other parameters (i.e.
- Trial name
- AF-EduCare (NCT03707873)
- Testing
- Education
- Where
- 3 sites in Belgium
- Volunteers
- 1,040 people
- Sponsor
- Universiteit Antwerpen
Atrial Fibrillation Fluttering
Safety and Initial Efficacy Study of a Cardiac Surgical Pulsed Field Ablation System for the Treatment of Atrial Fibrillation
This study is a prospective, single-center, single-arm, non-randomized study focused on safety and preliminary efficacy, aiming to evaluate the safety and preliminary efficacy of a cardiac pulsed field ablation device and a…
- Trial name
- NCT07410962
- Testing
- Cardiac pulse field ablation device and disposable cardiac surgical pulse field ablation electrode
- Volunteers
- 16 people
- Sponsor
- SuZhou Sinus Medical Technologies Co.,Ltd
Atrial Fibrillation, Atrial Flutter
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
The purpose of this study is to determine if an AF detection intervention in men and women at least 70 years of age with undiagnosed atrial fibrillation (AF) or atrial flutter (AFL) reduces the person-years incidence rate of…
- Trial name
- GUARD-AF (NCT04126486)
- Testing
- Zio®XT Monitor
- Where
- 176 sites in United States
- Volunteers
- 11,931 people
- Sponsor
- Bristol-Myers Squibb
Paroxysmal Atrial Fibrillation
ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study
The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal…
- Trial name
- ADVENT LTO (NCT06526546)
- Where
- 25 sites in United States
- Volunteers
- 364 people
- Sponsor
- Boston Scientific Corporation
Atrial Flutter Typical
Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation
Pulmonary vein isolation (PVI) via catheter ablation has been successfully employed for years to treat symptomatic atrial fibrillation (AF).
- Trial name
- PREVENT-AF II (NCT07649603)
- Testing
- Catheter ablation
- Volunteers
- 620 people
- Sponsor
- University of Rochester
Atrial Fibrillation, Atrial Flutter
DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery
This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.
- Trial name
- DETECT-POAF (NCT06519747)
- Testing
- Cardiac monitoring device
- Where
- 6 sites in Canada
- Volunteers
- 750 people
- Sponsor
- Population Health Research Institute